Business Description
Avacta Group PLC
ISIN : GB00BYYW9G87
Total Employee Number:
75Description
Avacta Group PLC is a clinical-stage life sciences company expanding the reach of potent cancer therapies with the pre-CISION platform. pre-CISION is a proprietary warhead delivery system based on a tumor-specific protease (fibroblast activation protein or FAP) that is designed to concentrate potent warheads in the tumor microenvironment while sparing normal tissues. The company's pipeline consists of pre-CISION peptide drug conjugates (PDC) or Affimer drug conjugates (AffDC) that leverage the tumor-specific release mechanism, providing benefits over traditional antibody drug conjugates. The firm has one reportable segment, Therapeutics, which is engaged in the development of novel cancer therapies harnessing its proprietary technology. Geographically, it derives revenue from South Korea.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.13 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 6.03 | |||||
Debt-to-EBITDA | -0.54 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.19 | |||||
Beneish M-Score | 4.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 20.4 | |||||
3-Year EPS without NRI Growth Rate | 6.6 | |||||
3-Year FCF Growth Rate | 2.6 | |||||
3-Year Book Growth Rate | -57.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.11 | |||||
9-Day RSI | 37.3 | |||||
14-Day RSI | 45.05 | |||||
3-1 Month Momentum % | 12 | |||||
6-1 Month Momentum % | 25.75 | |||||
12-1 Month Momentum % | 155.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.64 | |||||
Days Sales Outstanding | 9666.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.5 | |||||
Shareholder Yield % | -5.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -26053.1 | |||||
Net Margin % | -34169.91 | |||||
EBITDA Margin % | -24592.04 | |||||
FCF Margin % | -23795.39 | |||||
OCF Margin % | -23748.68 | |||||
ROE % | -973.33 | |||||
ROA % | -108.33 | |||||
ROIC % | -93.58 | |||||
3-Year ROIIC % | 5.1 | |||||
ROC (Joel Greenblatt) % | -478.17 | |||||
ROCE % | -560.08 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 121.67 | |||||
EV-to-EBIT | -11.7 | |||||
EV-to-EBITDA | -12.24 | |||||
EV-to-Revenue | 3009.75 | |||||
EV-to-Forward-Revenue | 9.63 | |||||
EV-to-FCF | -12.67 | |||||
Price-to-GF-Value | 1.54 | |||||
Earnings Yield (Greenblatt) % | -8.55 | |||||
FCF Yield % | -7.85 |
Avacta Group PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avacta Group PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-09-30 13:00 | In 98 days | ||
| Second quarter earnings results for 2026 | 2026-09-30 | In 97 days | ||
| General meeting for 2025 | 2026-06-22 08:00 | 1.00 (+0.00%) | ||
| Annual report for 2025 | 2026-05-29 | 1.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-05-19 13:00 | 1.23 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-05-19 | 1.23 (+0.00%) | ||
| 46th Annual TD Cowen Health Care Conference | 2026-03-03 09:10 | 0.93 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-09-30 13:00 | 0.75 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-09-30 | 0.75 (+0.00%) | ||
| General meeting for 2024 | 2025-07-02 09:00 | 0.40 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:AVCTF
No articles.
Press Release
Articles on Avacta Group PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers